Top Story

Tumor subtype provided prognostic factor for survival after WBRT for metastatic breast cancer

September 19, 2014

SAN FRANCISCO — Vipin Das Villgran, MD, medical resident at University of Pittsburgh Medical Center, discusses study results which found that tumor subtype predicted survival among patients with breast cancer who underwent whole-brain radiation therapy for brain metastases.

However, survival was not associated with tumor subtype among patients treated with stereotactic radiosurgery, results showed.

NIH director: Emerging biomedical research ‘breathtaking’

September 19, 2014
NIH director Francis Collins, MD, PhD, spoke to the audience at TEDMED 2014 about the advances in biomedical research on the horizon.“I have this amazing…
In the Journals

E-cigarettes emitted fewer carcinogenic particulates, higher toxic metals

September 19, 2014
Secondhand smoke from electronic cigarettes contained significantly fewer organic carcinogen emissions than tobacco-containing cigarettes, according to recent…
figure

UPenn, Wistar Institute to collaborate on $12 million SPORE grant

September 19, 2014
The Wistar Institute has announced that Meenhard Herlyn, DVM, DSc, will be the principal investigator on a $12.1 million…
More News Headlines »
Pharmacology Consult Publication Exclusive
figure

Emerging data will determine role of ramucirumab in treatment of advanced gastric cancer

HemOnc Today, July 25, 2014
Van Nguyen, PharmD, BCOP
Despite current therapies, gastric cancer remains the second leading cause of cancer-related mortality worldwide…
More »
Meeting News Coverage Video
figure

Tumor subtype provided prognostic factor for survival after WBRT for metastatic breast cancer

September 19, 2014
SAN FRANCISCO — Vipin Das Villgran, MD, medical resident at University of Pittsburgh Medical Center, discusses…
More »